action of glp-1 agonist What is and Its Receptor Agonists? A Comprehensive Review of the
Description
Characterized by emotional disturbances, stress, guilt, and treatment avoidance, DD affected approximately 45% of patients worldwide-a prevalence underscoring its clinical significance [Reference Parsa, Aghamohammadi and Abazari57]
doi:10.1016/j.molmet.2019.09.010 Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V
This is a newer active ingredient and lacks the same level of long-term safety data
Nutrients (2017) 9:869
Summary of Revisions
Hinnen DA
